Literature DB >> 29955824

Evaluation of Linguistic Markers of Word-Finding Difficulty and Cognition in Parkinson's Disease.

Kara M Smith1,2, Sharon Ash3, Sharon X Xie4, Murray Grossman3.   

Abstract

Purpose: Early cognitive symptoms such as word-finding difficulty (WFD) in daily conversation are common in Parkinson's disease (PD), but studies have been limited by a lack of feasible, quantitative measures. Linguistic analysis, focused on pauses in speech, may yield markers of impairment of cognition and communication in PD. The objective of this study was to evaluate the relationship of linguistic markers in semistructured speech to WFD symptoms and cognitive function in PD. Method: Speech recordings of description of the Cookie Theft picture in 53 patients with PD without dementia and 23 elderly controls were analyzed with Praat software. Montreal Cognitive Assessment (MoCA; Nasreddine et al., 2005), category naming fluency, and confrontation naming tests were administered. Questionnaires rating WFD symptoms and cognitive instrumental activities of daily living were completed. We determined the relationships between (a) pause length and location, (b) MoCA score, and (c) WFD symptoms, using Pearson's correlations and multivariate regression models.
Results: Compared with controls, patients with PD had more pauses within utterances as well as fewer words per minute and a lower percentage of well-formed sentences. Pauses within utterances differed significantly between PD-mild cognitive impairment and normal cognition (p < .001). Words per minute and percentage of well-formed sentences were predictive of MoCA in multivariate regression models. Pauses before verbs were associated with patient-reported severity of WFD symptoms (p = .006). Conclusions: Linguistic markers including pauses within utterances distinguish patients with PD with mild cognitive symptoms from elderly controls. These markers are associated with global cognitive function before the onset of dementia. Pauses before verbs and grammatical markers may index early cognitive symptoms such as WFD that may interfere with functional communication. Supplemental Material: https://doi.org/10.23641/asha.6615401.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29955824      PMCID: PMC6195062          DOI: 10.1044/2018_JSLHR-L-17-0304

Source DB:  PubMed          Journal:  J Speech Lang Hear Res        ISSN: 1092-4388            Impact factor:   2.297


  50 in total

1.  The roles of sequencing and verbal working memory in sentence comprehension deficits in Parkinson's disease.

Authors:  Jesse Hochstadt; Hiroko Nakano; Philip Lieberman; Joseph Friedman
Journal:  Brain Lang       Date:  2005-12-05       Impact factor: 2.381

2.  Non-Fluent Speech in Frontotemporal Lobar Degeneration.

Authors:  Sharon Ash; Peachie Moore; Luisa Vesely; Delani Gunawardena; Corey McMillan; Chivon Anderson; Brian Avants; Murray Grossman
Journal:  J Neurolinguistics       Date:  2009-07-01       Impact factor: 1.710

3.  Differentiating primary progressive aphasias in a brief sample of connected speech.

Authors:  Sharon Ash; Emily Evans; Jessica O'Shea; John Powers; Ashley Boller; Danielle Weinberg; Jenna Haley; Corey McMillan; David J Irwin; Katya Rascovsky; Murray Grossman
Journal:  Neurology       Date:  2013-06-21       Impact factor: 9.910

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

5.  Impairments of speech fluency in Lewy body spectrum disorder.

Authors:  Sharon Ash; Corey McMillan; Rachel G Gross; Philip Cook; Delani Gunawardena; Brianna Morgan; Ashley Boller; Andrew Siderowf; Murray Grossman
Journal:  Brain Lang       Date:  2011-11-17       Impact factor: 2.381

6.  Articulatory deficits in parkinsonian dysarthria: an acoustic analysis.

Authors:  H Ackermann; W Ziegler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-12       Impact factor: 10.154

7.  Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease.

Authors:  Maria Caterina Silveri; Nicoletta Ciccarelli; Eleonora Baldonero; Carla Piano; Massimiliano Zinno; Francesco Soleti; Anna Rita Bentivoglio; Alberto Albanese; Antonio Daniele
Journal:  Neuropsychologia       Date:  2012-05-07       Impact factor: 3.139

8.  The impact of executive functions on verb production in patients with Parkinson's disease.

Authors:  Katrien S F Colman; Janneke Koerts; Marije van Beilen; Klaus L Leenders; Wendy J Post; Roelien Bastiaanse
Journal:  Cortex       Date:  2009-02-28       Impact factor: 4.027

9.  The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.

Authors:  Caroline H Williams-Gray; Sarah L Mason; Jonathan R Evans; Thomas Foltynie; Carol Brayne; Trevor W Robbins; Roger A Barker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-06-18       Impact factor: 10.154

10.  Sentence comprehension and its association with executive functions in patients with Parkinson's disease.

Authors:  Katrien S F Colman; Janneke Koerts; Laurie A Stowe; Klaus L Leenders; Roelien Bastiaanse
Journal:  Parkinsons Dis       Date:  2011-10-24
View more
  3 in total

1.  The Impact of Parkinson's Disease on Breath Pauses and Their Relationship to Speech Impairment: A Longitudinal Study.

Authors:  Meghan Darling-White; Jessica E Huber
Journal:  Am J Speech Lang Pathol       Date:  2020-07-16       Impact factor: 2.408

2.  Comparing different approaches for operationalizing subjective cognitive decline: impact on syndromic and biomarker profiles.

Authors:  Patricia Diaz-Galvan; Daniel Ferreira; Nira Cedres; Farshad Falahati; Juan Andrés Hernández-Cabrera; David Ames; Jose Barroso; Eric Westman
Journal:  Sci Rep       Date:  2021-02-23       Impact factor: 4.379

3.  Spatio-Semantic Graphs From Picture Description: Applications to Detection of Cognitive Impairment.

Authors:  Pranav S Ambadi; Kristin Basche; Rebecca L Koscik; Visar Berisha; Julie M Liss; Kimberly D Mueller
Journal:  Front Neurol       Date:  2021-12-09       Impact factor: 4.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.